Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1992-11-13
1994-08-30
Lacey, David L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 723, 43524027, 5303877, 5303911, G01N 33574, A61K 39395, C07K 1528
Patent
active
053427572
ABSTRACT:
The invention involves monoclonal antibodies which specifically bind to a cell surface antigen characteristic of tumor vascular endothelium. The antigen, referred to as endosialin, is a glycoprotein and has a molecular weight of about 165 kDa as determined by SDS-PAGE. The protein portion of the molecule has a molecular weight of about 95 kDa. Also disclosed are various uses of the monoclonal antibody and the antigen.
REFERENCES:
Harris et al. TIBTECH 11: 42-44 (1993).
Rettig et al. PNAS 89: 10832-10836 (1992).
Ruiter et al. J. Invest. Dermatol 93: 255-325 (1989).
Schlingemann et al. Am. J. Pathol. 138: 1335-1347 (1991).
Dillman Annals Int. Med 111: 592-603 (1989).
Garin-Chesa et al. PNAS 87: 7235-7239 (1990).
Garin-Chesa Pilar
Old Lloyd J.
Rettig Wolfgang J.
Gambel Phillip
Lacey David L.
Ludwig Institute for Cancer Research
Memorial Sloan-Kettering Cancer Center
LandOfFree
Monoclonal antibodies which specifically binds to endosialin, a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies which specifically binds to endosialin, a , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies which specifically binds to endosialin, a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-29418